-
1
المؤلفون: Yaping Wu, Brendan D. Curti, Zhaoyu Sun, William L. Redmond, Brady Bernard, Christopher B. Fountain, Peter G. Traber, Takashi Shimada, Yoshinobu Koguchi, Rom Leidner, Eliezer Zomer, Elizabeth Sturgill, George Morris, Venkatesh Rajamanickam, Noriko Iwamoto, Annah S Rolig, Ian Hilgart-Martiszus, J. Rex Horton, Shu Ching Chang, Harold Shlevin
المصدر: Journal for ImmunoTherapy of Cancer, Vol 9, Iss 4 (2021)
Journal for Immunotherapy of Cancerمصطلحات موضوعية: 0301 basic medicine, Oncology, Male, Cancer Research, Time Factors, medicine.medical_treatment, Programmed Cell Death 1 Receptor, Pembrolizumab, 0302 clinical medicine, Antineoplastic Combined Chemotherapy Protocols, Immunology and Allergy, Immune Checkpoint Inhibitors, T-lymphocytes, RC254-282, Clinical/Translational Cancer Immunotherapy, clinical trials as topic, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Blood Proteins, Middle Aged, Treatment Outcome, Head and Neck Neoplasms, 030220 oncology & carcinogenesis, immunohistochemistry, Molecular Medicine, Pectins, Female, Multiple Myeloma, Adult, medicine.medical_specialty, Galectins, Immunology, Antibodies, Monoclonal, Humanized, 03 medical and health sciences, Memory T Cells, Immune system, Internal medicine, medicine, Humans, Aged, Pharmacology, Autoimmune disease, business.industry, Squamous Cell Carcinoma of Head and Neck, Myeloid-Derived Suppressor Cells, Immunotherapy, medicine.disease, Head and neck squamous-cell carcinoma, Blockade, 030104 developmental biology, Myeloid-derived Suppressor Cell, business, CD8
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a1c844347afeb00988b18adab8210aeTest
https://jitc.bmj.com/content/9/4/e002371.fullTest -
2
المؤلفون: Yukie Umemori, Toshiyuki Ozawa, Dai Ogata, Akimichi Morita, Maki Yoshimitsu, Yukiko Teramoto, Tadahiro Kobayashi, Kotaro Nagase, Yuka Nojiri, Masahito Yasuda, Motoki Nakamura, Hidefumi Wada, Hiroshi Kato, Tetsuya Magara
المصدر: Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Journal for Immunotherapy of Cancerمصطلحات موضوعية: Adult, Male, 0301 basic medicine, Cancer Research, Skin Neoplasms, medicine.medical_treatment, Immunology, Gene Expression, Glucosephosphate Dehydrogenase, programmed cell death 1 receptor, B7-H1 Antigen, 03 medical and health sciences, 0302 clinical medicine, Blood serum, Immune system, Immunotherapy Biomarkers, medicine, Humans, Immunology and Allergy, RNA, Neoplasm, Lymph node, RC254-282, Aged, Aged, 80 and over, Pharmacology, business.industry, Merkel cell carcinoma, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Immunotherapy, Middle Aged, medicine.disease, Up-Regulation, Carcinoma, Merkel Cell, 030104 developmental biology, medicine.anatomical_structure, Oncology, tumor biomarkers, 030220 oncology & carcinogenesis, Cancer research, Molecular Medicine, Immunohistochemistry, Female, immunotherapy, Skin cancer, Merkel cell, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f22d76c7c8338d7c670671594b281d3Test
https://jitc.bmj.com/content/8/2/e001679.fullTest -
3
المؤلفون: Isabell Speit, Sandra P. D'Angelo, Karen Kelly, Marcis Bajars, Vijay Kasturi, Arun Rajan, Juliane Manitz, Manish R. Patel, James L. Gulley, Andrea B. Apolo, John Warth
المصدر: Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Journal for Immunotherapy of Cancerمصطلحات موضوعية: 0301 basic medicine, Oncology, Adult, Male, Cancer Research, medicine.medical_specialty, Drug-Related Side Effects and Adverse Reactions, Immune checkpoint inhibitors, medicine.medical_treatment, Immunology, Improved survival, biostatistics, Antibodies, Monoclonal, Humanized, programmed cell death 1 receptor, Avelumab, 03 medical and health sciences, Young Adult, 0302 clinical medicine, Immune system, Antineoplastic Agents, Immunological, Internal medicine, medicine, Immunology and Allergy, Humans, Adverse effect, RC254-282, Aged, Pharmacology, Aged, 80 and over, Clinical/Translational Cancer Immunotherapy, business.industry, Proportional hazards model, Confounding, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Immunotherapy, Middle Aged, 030104 developmental biology, 030220 oncology & carcinogenesis, Molecular Medicine, Female, immunotherapy, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f3df9809ae6ddcc1d0ceaf44360b85cTest
https://jitc.bmj.com/content/8/2/e001427.fullTest -
4
المؤلفون: Stefania Cuzzubbo, Barouyr Baroudjian, P. Tetu, Sarah Guégan, Renata Ursu, Catherine Belin, Céleste Lebbé, C. Lheure, Julie Mazoyer, Lila Sirven Villaros, Antoine F. Carpentier
المصدر: Journal for Immunotherapy of Cancer
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)مصطلحات موضوعية: Adult, Male, CTLA-4 antigen, Cancer Research, medicine.medical_specialty, medicine.medical_treatment, Immunology, programmed cell death 1 receptor, 03 medical and health sciences, 0302 clinical medicine, Cerebrospinal fluid, Immune system, Prednisone, Internal medicine, medicine, melanoma, Immunology and Allergy, Cytotoxic T cell, Humans, Meningitis, Adverse effect, Immune Checkpoint Inhibitors, RC254-282, Aged, Pharmacology, Clinical/Translational Cancer Immunotherapy, business.industry, Melanoma, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Immunotherapy, Middle Aged, medicine.disease, Oncology, 030220 oncology & carcinogenesis, Molecular Medicine, Female, immunotherapy, business, 030217 neurology & neurosurgery, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5785e8d88f96465af3dba28222de387aTest
https://pubmed.ncbi.nlm.nih.gov/32747471Test -
5
المؤلفون: Adrien Costantini, Paul Takam Kamga, Thierry Chinet, Jean-François Emile, Etienne Giroux Leprieur, Simon Garinet, Sylvie Labrune, Alexandre Corjon, Zofia Hélias-Rodzewicz, Coraline Dumenil, Catherine Julie, Violaine Giraud, Jennifer Dumoulin
المساهمون: Université de Versailles Saint-Quentin-en-Yvelines (UVSQ), Hôpital Ambroise Paré [AP-HP], Service de pathologie [CHU Ambroise Paré], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Ambroise Paré [AP-HP], Hôpital Européen Georges Pompidou [APHP] (HEGP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)
المصدر: Journal for ImmunoTherapy of Cancer, Vol 8, Iss 1 (2020)
Journal for Immunotherapy of Cancer
Journal for Immunotherapy of Cancer, BMJ Publishing Group 2020, 8 (1), ⟨10.1136/jitc-2020-000527⟩مصطلحات موضوعية: Male, 0301 basic medicine, Oncology, Cancer Research, Lung Neoplasms, Time Factors, DNA Mutational Analysis, Programmed Cell Death 1 Receptor, Pembrolizumab, B7-H1 Antigen, Circulating Tumor DNA, 0302 clinical medicine, biomarkers, tumor, Carcinoma, Non-Small-Cell Lung, Immunology and Allergy, Immune Checkpoint Inhibitors, Lung, Exome sequencing, RC254-282, Clinical/Translational Cancer Immunotherapy, Aged, 80 and over, biology, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Middle Aged, Progression-Free Survival, 3. Good health, Nivolumab, 030220 oncology & carcinogenesis, Disease Progression, Molecular Medicine, Adenocarcinoma, Female, Microsatellite Instability, Drug Monitoring, Adult, tumor, medicine.medical_specialty, DNA Copy Number Variations, Immunology, [SDV.CAN]Life Sciences [q-bio]/Cancer, Antibodies, Monoclonal, Humanized, 03 medical and health sciences, Immune system, Internal medicine, Exome Sequencing, medicine, Humans, PTEN, Lung cancer, Aged, Neoplasm Staging, Retrospective Studies, Pharmacology, business.industry, biomarkers, medicine.disease, 030104 developmental biology, Drug Resistance, Neoplasm, Tumor progression, Mutation, biology.protein, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1163b2ec4ec67cc845a625d4e2161bc0Test
https://jitc.bmj.com/content/8Test/1 /e000527.full -
6
المؤلفون: Katarzyna Jozwiak, Helmut Forstbauer, Valery Volk, Eva-Maria Grischke, Claudia Schumacher, Christoph Uleer, Hans Kreipe, Michael Hauptmann, Oleg Gluz, Rachel Wuerstlein, John Hackmann, Michael Braun, Bahriye Aktas, Ulrike Nitz, Monika Graeser, Ronald E. Kates, Nadia Harbeck, Sherko Kuemmel, Cornelia Kolberg-Liedtke, Matthias Christgen, Friedrich Feuerhake, Mathias Warm
المصدر: Journal for ImmunoTherapy of Cancer, Vol 9, Iss 5 (2021)
Journal for Immunotherapy of Cancerمصطلحات موضوعية: CD4-Positive T-Lymphocytes, 0301 basic medicine, Oncology, Cancer Research, Time Factors, medicine.medical_treatment, Programmed Cell Death 1 Receptor, Medizin, Triple Negative Breast Neoplasms, CD8-Positive T-Lymphocytes, B7-H1 Antigen, 0302 clinical medicine, Germany, breast neoplasms, Tumor Microenvironment, Immunology and Allergy, Prospective Studies, RC254-282, Triple-negative breast cancer, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Middle Aged, Immunohistochemistry, Neoadjuvant Therapy, Treatment Outcome, medicine.anatomical_structure, Chemotherapy, Adjuvant, 030220 oncology & carcinogenesis, Molecular Medicine, Female, Adjuvant, immune evation, Adult, tumor, medicine.medical_specialty, T cell, Clinical Decision-Making, Immunology, 03 medical and health sciences, Lymphocytes, Tumor-Infiltrating, Breast cancer, Immune system, Stroma, Predictive Value of Tests, Internal medicine, Biomarkers, Tumor, medicine, Humans, Pharmacology, Tumor microenvironment, business.industry, biomarkers, Basic Tumor Immunology, medicine.disease, 030104 developmental biology, business, CD8
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c299138b359700ab88d542e24e895e9Test
https://doi.org/10.1136/jitc-2020-002198Test -
7
المؤلفون: Alexia Iasonos, Keith L. Knutson, Yanyun Li, Roisin E. O'Cearbhaill, Jean Torrisi, Lewis Chesebrough, Taha Merghoub, Courtney L. Erskine, Mathew S Block, Jason A. Konner, Rachel N. Grisham, Travis J. Hollmann, Autumn S. McDonnell, Dmitriy Zamarin, Carol Aghajanian, Sven Walderich, Aliya Holland, Jacqueline Gallagher, Qin Zhou
المصدر: Journal for Immunotherapy of Cancer
مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, Durvalumab, Non-Randomized Controlled Trials as Topic, clinical trials, phase II as topic, Antineoplastic Agents, Immunological, 0302 clinical medicine, Tumor Microenvironment, Immunology and Allergy, Ovarian Neoplasms, education.field_of_study, Immunogenicity, Antibodies, Monoclonal, Middle Aged, Prognosis, Gene Expression Regulation, Neoplastic, Survival Rate, Vaccination, Treatment Outcome, medicine.anatomical_structure, 030220 oncology & carcinogenesis, Molecular Medicine, Drug Therapy, Combination, Female, Adult, Folate Receptor Alpha, medicine.medical_specialty, T cell, Immunology, Population, immunogenicity, vaccine, Cancer Vaccines, programmed cell death 1 receptor, 03 medical and health sciences, Immune system, Internal medicine, Biomarkers, Tumor, medicine, Humans, Folate Receptor 1, education, Aged, Pharmacology, Tumor microenvironment, business.industry, Clinical Trials Monitor, Cystadenocarcinoma, Serous, Endometrial Neoplasms, 030104 developmental biology, antigens, neoplasm, business, Adenocarcinoma, Clear Cell, Follow-Up Studies
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eac64e64a8202e3e031b292b42295d80Test
https://doi.org/10.1136/jitc-2020-000829Test -
8
المؤلفون: Sandra Demaria, Silvia C. Formenti, Muriel Brackstone, Emanuela Romano
المصدر: Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-4 (2019)
Journal for Immunotherapy of Cancerمصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, medicine.medical_treatment, Programmed Cell Death 1 Receptor, Triple Negative Breast Neoplasms, B7-H1 Antigen, 0302 clinical medicine, Antineoplastic Agents, Immunological, Tumor Microenvironment, Immunology and Allergy, Neoplasm Metastasis, Triple-negative breast cancer, Middle Aged, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Combined Modality Therapy, 3. Good health, Immunogenic cell death, tumor burden, Nivolumab, 030220 oncology & carcinogenesis, Molecular Medicine, Female, Immunotherapy, medicine.drug, Adult, medicine.medical_specialty, Cyclophosphamide, Immunology, Breast Neoplasms, lcsh:RC254-282, Immunomodulation, 03 medical and health sciences, Immune system, Internal medicine, medicine, Humans, Doxorubicin, Aged, Pharmacology, Cisplatin, business.industry, Tumor-infiltrating T cells, Blockade, Radiation therapy, 030104 developmental biology, Concomitant, Commentary, Radiotherapy, Adjuvant, business, T-Lymphocytes, Cytotoxic
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3cc449295f6390e051c7848cff7a10b2Test
https://pubmed.ncbi.nlm.nih.gov/31086347Test -
9
المؤلفون: Aye Aye Thike, Jeffrey Chun Tatt Lim, Rebecca Dent, Bernett Lee, Evan W. Newell, Timothy Kwang Yong Tay, Elaine Hsuen Lim, Yi Yang, Clara Chong Hui Ong, Ansel Yi Herh Lim, Joe Yeong, Siew Cheng Wong, Puay Hoon Tan, Jin Liu, Huihua Li, Jabed Iqbal, Wei Hseun Yeap, Jinmiao Chen
المصدر: Journal for Immunotherapy of Cancer
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-13 (2019)مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, Programmed Cell Death 1 Receptor, Triple Negative Breast Neoplasms, B7-H1 Antigen, 0302 clinical medicine, Gene expression, PD-1, Immunology and Allergy, Triple-negative breast cancer, Aged, 80 and over, biology, Middle Aged, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Prognosis, Gene Expression Regulation, Neoplastic, 030220 oncology & carcinogenesis, Molecular Medicine, Biomarker (medicine), Female, Immune checkpoint, Antibody, TNBC, Research Article, Adult, PD-L1, medicine.medical_specialty, CD8 Antigens, Immunology, lcsh:RC254-282, 03 medical and health sciences, Immune system, Internal medicine, Cell Line, Tumor, medicine, Humans, RNA, Messenger, Aged, Pharmacology, business.industry, IFNG, Survival Analysis, 030104 developmental biology, biology.protein, business, CD8
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ed3b6bc98e7dc2601f2aa23e3667352Test
https://pubmed.ncbi.nlm.nih.gov/30728081Test -
10
المؤلفون: Evan J. Lipson, Mohammed T. Lilo, Aleksandra Ogurtsova, Jessica Esandrio, Haiying Xu, Patricia Brothers, Megan Schollenberger, William H. Sharfman, Janis M. Taube
المصدر: Journal for Immunotherapy of Cancer
مصطلحات موضوعية: 0301 basic medicine, Adult, Male, PD-L1, Cancer Research, Pathology, medicine.medical_specialty, Immunology, Programmed Cell Death 1 Receptor, Short Report, Pembrolizumab, Antibodies, Monoclonal, Humanized, B7-H1 Antigen, 03 medical and health sciences, 0302 clinical medicine, Immune system, Lymphocytes, Tumor-Infiltrating, medicine, Tumor Microenvironment, Immunology and Allergy, Humans, Basal cell carcinoma, Hedgehog Proteins, Hedgehog, Aged, Pharmacology, Tumor microenvironment, biology, Tumor-infiltrating lymphocytes, Antibodies, Monoclonal, Middle Aged, medicine.disease, Hedgehog signaling pathway, Anti-PD-1, 3. Good health, Gene Expression Regulation, Neoplastic, 030104 developmental biology, Oncology, Carcinoma, Basal Cell, 030220 oncology & carcinogenesis, biology.protein, Molecular Medicine, Female, Signal Transduction
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce4eb393dcf68ebc6566e595d2349b8fTest